Regeneron Pharmaceuticals (REGN34.SA) Q2 2022 Earnings

4MayConfirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
43.92
74.39
104.86
135.33

Details

Expected EPS
47.909112
Actual EPS
43.924884
Surprise EPS
-3.98
Surprise Percent
+8.32%

Description

Regeneron Pharmaceuticals (REGN34.SA) has reported earnings of 43.924884 per share for Q2 2022.

0 Comments

Share your thoughts